Proteasome inhibition overcomes the resistance of renal cell carcinoma cells against the PPARγ ligand troglitazone

In order to analyze the effects of peroxisome proliferator-activated receptor-γ (PPARγ) activation on renal cell carcinomas we utilized several cell lines that were treated with the high affinity PPARγ agonist, troglitazone. Incubation of RCC cells with troglitazone resulted in reduced secretion of...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Cellular and molecular life sciences : CMLS 2009-04, Vol.66 (7), p.1295-1308
Hauptverfasser:	von Schwarzenberg, K, Held, S. A. E, Schaub, A, Brauer, K. M, Bringmann, A, Brossart, P
Format:	Artikel
Sprache:	eng
Schlagworte:	apoptosis Biochemistry Biomedical and Life Sciences Biomedicine Cell Biology Life Sciences PPARγ proteasome inhibition Renal cell carcinoma Research Article signal pathways
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!